Albert Koong, MD, PhD, becomes the new Chief Scientific Officer at UT MD Anderson Cancer Center.
Key Details
- 1Albert Koong, MD, PhD, formally appointed as UT MD Anderson's Chief Scientific Officer effective June 1, 2026.
- 2Previously served as interim CSO since January 1, 2026.
- 3Role includes overseeing laboratory and clinical research, fostering innovation, and supporting AI-driven scientific advancement.
- 4Has led as division head of Radiation Oncology and contributed significantly to GI radiation oncology research.
- 5Recognized with honors such as Fellow of the American College of Radiology (FACR) and American Society for Radiation Oncology (FASTRO).
Why It Matters
Leadership at a prominent cancer center, especially with expertise in radiation oncology and ties to AI advancement, influences radiology and imaging research directions and collaborations. This appointment further signals ongoing integration of AI in cancer science by institutional leaders.
Source
EurekAlert
Related News
•EurekAlert
New G-AUDIT Tool Detects Hidden Bias in Medical AI Training Data
Johns Hopkins and FDA researchers unveil G-AUDIT, a tool to identify hidden biases in medical AI datasets before model training.
•EurekAlert
AI-Driven Bone Marrow Mapping Tool Improves Blood Cancer Assessment
Weill Cornell Medicine develops an AI tool to score and track disease severity in blood cancer from bone marrow imaging.
•EurekAlert
AI-Assisted Imaging Advances Precision in Brain Tumor Therapy Delivery
An AI-guided method improves intra-arterial therapy by mapping all tumor-feeding arteries to enhance delivery accuracy in malignant brain tumor treatment.